Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted Towards Tumor-Associated Hypoxia

Ítems similars

• Bioreductively Activatable Prodrug Conjugates of Phenstatin Designed to Target Tumor Hypoxia
  per: Winn, Blake A., et al.
  Publicat: (2016)
• Design, Synthesis, and Biological Evaluation of Water-Soluble Amino Acid Prodrug Conjugates Derived from Combretastatin, Dihydronaphthalene, and Benzosuberene-Based Parent Vascular Disrupting Agents
  per: Devkota, Laxman, et al.
  Publicat: (2016)
• Structure Guided Design, Synthesis and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization
  per: Niu, Haichan, et al.
  Publicat: (2019)
• Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3′-hydroxy-4′-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006)
  per: MacDonough, Matthew T., et al.
  Publicat: (2013)
• Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents
  per: Maguire, Casey J., et al.
  Publicat: (2018)